Skip to main content
Home
language-selector-globe Korea | ko
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Korea
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • 회사소개 
      • 주요 전략 
      • 직원과 기업문화 
      • 다양성과 포용성 
      • 제품정보  
      • 노바티스그룹 경영진 
      • 핵심 사업부문 
      • 연락처 
      About Novartis Korea 회사소개
    • 환자와 보호자 
      • 환자와 보호자에 대한 노바티스의 약속 
      • 주요 질병 분야 
      • 제품정보  
      • 부작용 보고 
      A couple holding hands 환자와 보호자
    • 의료전문가 
      • 메드허브 
      • 제품정보  
      • 부작용 보고 
      • 혁신 
      • 글로벌 정보서비스 
      Novartis Health Care 의료전문가
    • 혁신 
      • 임상시험 
      • 기술 플랫폼 
      • 데이터와 디지털 
      • 한국노바티스의 혁신 
      • 노바티스의 혁신 
      • 노바티스 생명의학연구소(NIBR) 
      Novartis Innovation 혁신
    • 환경, 사회 및 가브넌스 
      • 윤리 위험 및 규정준수 
      • 의약품 접근성 
      • 환경지속가능성 
      • 글로벌 헬스 
      • 윤리적 행동양식 
      • 한국노바티스의 사회적 책임 
      Novartis ESG 환경, 사회 및 가브넌스
    • 뉴스룸 
      • 보도자료  
      • 이노베이션 스토리  
      • 자료실 
        • 의약품 회수에 관한 공표 
      Novartis News 뉴스룸
    • 인재채용 
      • 채용 공고 
      • 우리가 일하는 방식 
      • 웰빙 
      • 다양성과 포용성  
      • 수상내역 
      Novartis Careers 인재채용
    • Coronavirus 
      multiple coronavirus illustration edit image_1 코로나바이러스감염증-19 (COVID-19) 업데이트
    Seoul Skyline Home
  1. Home
  2. 인재채용
  3. 채용 공고
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Global R2R PEC Automation Expert Hyderabad (Office) India Finance CTS Audit & Finance Oct 09, 2024
LDC Core Enablement Business and IT Controls Hyderabad (Office) India Operations CTS Audit & Finance Oct 09, 2024
Data Analyst, Digital Finance Hyderabad (Office) India Operations Innovative Medicines Audit & Finance Oct 09, 2024
Manager, Digital Finance Hyderabad (Office) India Finance Innovative Medicines Audit & Finance Oct 09, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 09, 2024
Senior Financial Analyst - Digital Finance Hyderabad (Office) India Finance Corporate Audit & Finance Oct 08, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 08, 2024
Senior Finance Specialist – Digital Analytics and Operations Barcelona Gran Vía Spain Finance Innovative Medicines Audit & Finance Oct 08, 2024
Expert Analyst – Management Reporting Prague Czech Republic Finance Corporate Audit & Finance Oct 08, 2024
FRA Specialist - Asset Management Prague Czech Republic Finance CTS Audit & Finance Oct 08, 2024
Global Finance Master Data Sr Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 08, 2024
Commercial BPA Manager Montreal Canada International Innovative Medicines Audit & Finance Oct 08, 2024
Finance Control and Compliance US Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 08, 2024
Chef commercial BPA Montreal Canada International Innovative Medicines Audit & Finance Oct 08, 2024
FC&C Head - HUB/ECI Hyderabad (Office) India Finance CTS Audit & Finance Oct 07, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexico Finance CTS Audit & Finance Oct 07, 2024
Tax Manager (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Oct 06, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Oct 04, 2024
Assistant Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 03, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Czech Republic Finance CTS Audit & Finance Oct 03, 2024
Source to Pay Business Partner Argentina / Chile INSURGENTES Mexico Finance CTS Audit & Finance Oct 03, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Oct 02, 2024
P2P Process Excellence INSURGENTES Mexico Operations CTS Audit & Finance Oct 02, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spain Finance Corporate Audit & Finance Oct 01, 2024
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Sep 27, 2024
Business Planning Analysis Manager / Analyst INSURGENTES Mexico Biomedical Research CTS Audit & Finance Sep 27, 2024
Procure to Pay Business Partner GDD and M&A SPOC INSURGENTES Mexico Operations CTS Audit & Finance Sep 27, 2024
Senior FRA Specialist GL Prague Czech Republic Finance CTS Audit & Finance Sep 26, 2024
Financial IT Compliance Senior Specialist Prague Czech Republic Finance CTS Audit & Finance Sep 25, 2024
Financial IT Compliance Manager Prague Czech Republic Finance CTS Audit & Finance Sep 25, 2024
Order Management Specialist INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Sep 25, 2024
Order Management Specialist - Temporary INSURGENTES Mexico Finance CTS Audit & Finance Sep 25, 2024
S2P Business Partner (Korean speaker) Selangor Malaysia Finance CTS Audit & Finance Sep 24, 2024
Revenue Accounting Supervisor Shanghai (Shanghai) China Finance CTS Audit & Finance Sep 24, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Sep 23, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit & Finance Sep 17, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Sep 17, 2024
R2R Lead Israel Israel Israel Finance CTS Audit & Finance Sep 16, 2024
FRA Analyst Treasury and Cash Management / Analitik - specialist Ljubljana Slovenia Finance CTS Audit & Finance Sep 15, 2024
Analitik - specialist / FRA Analyst-specialist Ljubljana Slovenia Finance CTS Audit & Finance Sep 15, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Sep 13, 2024
Finance Project Specialist Moscow (City) Russian Fed. Finance Innovative Medicines Audit & Finance Sep 11, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance Sep 06, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Sep 05, 2024

Pagination

  • 1
  • 2
  • › Next page

한국노바티스

Navigate Novartis
  • 회사소개
  • 환자와 보호자
  • 의료전문가
  • 혁신
  • 환경, 사회 및 가브넌스
  • 뉴스룸
  • 인재채용
Media Center
  • 보도자료
  • 이노베이션 스토리
Other Novartis Websites in Korea
  • MedHub
  • Novartis Global
  • 한국노바티스 LinkedIn
  • 한국노바티스 YouTube
Footer Bottom
© 2024 Novartis AG
  • 개인정보 처리방침
  • 이용약관
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
이 사이트는 국내 거주자들을 위한 사이트입니다. KR2205234431